Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
78.88
-3.63 (-4.40%)
Jun 16, 2026, 4:00 PM EDT - Market closed
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $4.31 billion as of June 16, 2026. Its market cap has increased by 664.87% in one year.
Market Cap
4.31B
Enterprise Value
3.09B
1-Year Change
664.87%
Ranking
Category
Stock Price
$78.88
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $4.31B, an increase of 2,545.53%. That is a compound annual growth rate of 227.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 4.31B | 144.04% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CG Oncology | 5.25B |
| Caris Life Sciences | 5.14B |
| Ligand Pharmaceuticals | 5.08B |
| CRISPR Therapeutics AG | 5.07B |
| Xenon Pharmaceuticals | 5.07B |
| Travere Therapeutics | 5.00B |
| Tango Therapeutics | 4.76B |
| Erasca | 4.49B |